Cabozantinib plus Nivolumab Phase I Expansion Study in Patients with Metastatic Urothelial Carcinoma Refractory to Immune Checkpoint Inhibitor Therapy
卡博替尼联合纳武利尤单抗治疗对免疫检查点抑制剂疗法耐药的转移性尿路上皮癌患者的I期扩展研究
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-21-3726
Girardi, Daniel M; Niglio, Scot A; Mortazavi, Amir; Nadal, Rosa; Lara, Primo; Pal, Sumanta K; Saraiya, Biren; Cordes, Lisa; Ley, Lisa; Ortiz, Olena Sierra; Cadena, Jacqueline; Diaz, Carlos; Bagheri, Hadi; Redd, Bernadette; Steinberg, Seth M; Costello, Rene; Chan, Keith S; Lee, Min-Jung; Lee, Sunmin; Yu, Yunkai; Gurram, Sandeep; Chalfin, Heather J; Valera, Vladimir; Figg, William D; Merino, Maria; Toubaji, Antoun; Streicher, Howard; Wright, John J; Sharon, Elad; Parnes, Howard L; Ning, Yang-Min; Bottaro, Donald P; Cao, Liang; Trepel, Jane B; Apolo, Andrea B